http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2606274-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82fa225614cc561caf161eecdd2ac876
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-389
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-0488
filingDate 2015-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d23c7f7a70bd5bb5a4b2e67d741ef146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f72324d25ae20a5ea29784a8a298d74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e54dc56636352f02e7190c548605516
publicationDate 2017-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2606274-C1
titleOfInvention Method for prediction of myasthenia generalization accompanying eye symptoms
abstract FIELD: medicine. n SUBSTANCE: invention relates to medicine, namely to neurology, and can be used for prediction of onset in myasthenia generalization with eye symptoms. Following things are determined: patient's sex, M-response amplitude decrement in studying of neuromuscular transmission with circular eye muscles, resistance to anticholinesterase agents. Values are assessed in points. Forecasting (Fp) is calculated by formula. If Fp equals to 0.8 and more, generalized myasthenia is predicted. n EFFECT: method enables to obtain information on probability of myasthenia generalization in short terms after diagnosis and improve prognosis of disease by assessing most significant parameters. n 1 cl, 1 dwg, 1 tbl, 2 ex
priorityDate 2015-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7550
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410862584
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453398165

Total number of triples: 20.